Stay Informed
Sign up to automatically receive Neurocrine Biosciences financial information by email
Webcasts & Presentations
Neurocrine Biosciences’ management team participates in industry conferences providing presentations on company updates and progress on research and development activities. The company conducts webcasts and conference calls for these conferences and provides financial highlights and company news updates during regularly scheduled conference calls. Webcast replays are typically available up to 30 days following any event. For questions or information on current or future webcasts and conference calls contact ir@neurocrine.com.
February 25, 2025
Neurocrine Biosciences to Present at the TD Cowen 45th Annual Health Care Conference
SAN DIEGO, February 25, 2025 - Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will present at the TD Cowen 45th Annual Health Care Conference at 11:10 a.m. Eastern Time on Tuesday, March 4, 2025 in Boston. Chief Executive Officer Kyle Gano, Chief Financial Officer Matt Abernethy, and Chief Commercial Officer Eric Benevich will present at the conference.
February 25, 2025
Neurocrine Biosciences to Present at the Leerink Global Healthcare Conference
SAN DIEGO, February 25, 2025 - Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will present at the Leerink Global Healthcare Conference on Tuesday, March 11, 2025 at 11:20 a.m. Eastern Time in Miami. Chief Financial Officer Matt Abernethy and Vice-President of Investor Relations Todd Tushla will present at the conference.
February 6, 2025
Neurocrine Biosciences Conference Call and Webcast of Fourth Quarter and Year-End 2024 Financial Results
Neurocrine Biosciences, Inc. (Nasdaq: NBIX) has scheduled its fourth quarter and year-end 2024 financial results conference call and webcast for 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) on Thursday February 6, 2025.
Resources